Marine Derived Drugs Market Scope And Analysis

  • Report Code : TIPRE00023145
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse de la dynamique et de la portée du marché des médicaments d'origine marine d'ici 2025-2031

Buy Now

Marine-derived Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 8.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • phénol
  • stéroïde
  • éther
  • peptide
  • autre
By Source
  • algues
  • invertébrés
  • micro-organismes
By Mode d'administration
  • antimicrobien
  • antitumoral
  • anticardiovasculaire
  • antiviral
  • anti-inflammatoire
  • autres
By Utilisateurs finaux
  • hôpitaux et cliniques
  • pharmacies
  • autres
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer, Inc.
  • Abbott
  • GlaxoSmithKline PLC
  • Aker BioMarine AS
  • Pharma Mar S.A
  • Eisai Co., Ltd.
  • Aker BioMarine AS
  • Sea Run Holdings, Inc.
  • Aphios Corporation